Literature DB >> 27254806

Potential for Drug-Drug Interactions with Adjunctive Tramadol Use in Treatment of Obsessive-Compulsive Disorder.

Eric E Brown1, Simon Davies2.   

Abstract

Entities:  

Keywords:  drug interactions; obsessive-compulsive disorder; tramadol

Mesh：

Substances：

Year:  2016        PMID： 27254806      PMCID： PMC4841283          DOI： 10.1177/0706743716633423

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  6 in total

1.  Rapid remission of OCD with tramadol hydrochloride.

Authors:  T B Goldsmith; N A Shapira; P E Keck
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

Review 2.  Clinical practice guidelines. Management of anxiety disorders.

Authors: 
Journal:  Can J Psychiatry       Date:  2006-07       Impact factor: 4.356

3.  Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder.

Authors:  N A Shapira; P E Keck; T D Goldsmith; B J McConville; M Eis; S L McElroy
Journal:  Depress Anxiety       Date:  1997       Impact factor: 6.505

4.  PharmGKB summary: tramadol pathway.

Authors:  Li Gong; Ulrike M Stamer; Mladen V Tzvetkov; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-07       Impact factor: 2.089

Review 5.  Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors.

Authors:  Elana M Nelson; Ann M Philbrick
Journal:  Ann Pharmacother       Date:  2012-12-04       Impact factor: 3.154

Review 6.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.